Ekso Bionics (NASDAQ:EKSO – Get Free Report)‘s stock had its “buy” rating reissued by research analysts at HC Wainwright in a report released on Tuesday,Benzinga reports. They presently have a $9.00 price target on the stock.
A number of other research analysts also recently weighed in on EKSO. Lake Street Capital cut their price target on Ekso Bionics from $2.50 to $2.00 and set a “buy” rating on the stock in a research note on Tuesday, October 29th. StockNews.com began coverage on Ekso Bionics in a report on Tuesday. They set a “hold” rating on the stock.
Read Our Latest Analysis on EKSO
Ekso Bionics Stock Down 9.7 %
Ekso Bionics (NASDAQ:EKSO – Get Free Report) last announced its quarterly earnings data on Monday, October 28th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.08) by ($0.02). Ekso Bionics had a negative return on equity of 83.09% and a negative net margin of 62.95%. The firm had revenue of $4.13 million for the quarter, compared to the consensus estimate of $6.00 million. During the same period in the prior year, the firm posted ($0.24) earnings per share. On average, analysts anticipate that Ekso Bionics will post -0.48 EPS for the current year.
Ekso Bionics Company Profile
Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.
Recommended Stories
- Five stocks we like better than Ekso Bionics
- Airline Stocks – Top Airline Stocks to Buy Now
- Is a Ford Stock Turnaround on the Horizon?
- Utilities Stocks Explained – How and Why to Invest in Utilities
- What PMI Data Says About the NFP Report: 3 Hidden Opportunities
- Pros And Cons Of Monthly Dividend Stocks
- Cintas: Trade Uncertainty Creates a Buy-the-Dip Opportunity
Receive News & Ratings for Ekso Bionics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekso Bionics and related companies with MarketBeat.com's FREE daily email newsletter.